Literature DB >> 15006160

Retinoic acid induces corneal epithelial CYP4B1 gene expression and stimulates the synthesis of inflammatory 12-hydroxyeicosanoids.

Silvia Ashkar1, Alexandre Mesentsev, Wen-Xiang Zhang, Vladimir Mastyugin, Michael W Dunn, Michal Laniado-Schwartzman.   

Abstract

Injury to the ocular surface provokes an inflammatory response that is mediated, at least in part, by corneal epithelial derived 12-hydroxyeicosanoids (HETEs) including 12-HETE and 12-HETrE; both metabolites exhibit potent inflammatory and angiogenic properties and are formed by a cytochrome P450 (CYP) 4B1. Retinoids are known to mediate wound-healing processes in many tissues and, as such, are integral components of the inflammatory response. We studied the effect of various retinoids on corneal synthesis of 12-hydroxyeicosanoids and on activation of CYP4B1 gene expression. Corneal organ cultures were used to assess the effect of retinoic acid on epithelial metabolism of arachidonic acid to 12-hydroxyeicosanoids. Luciferase reporter vectors containing different lengths of the CYP4B1 3.4 kb-5'-untranslated region were used to examine the effect of vitamin D and retinoids (9-cis-retinoic acid and all-trans retinoic acid) on transcriptional activation of CYP4B1 in transient transfection experiments with HepG2 cells. Vitamin D had no effect on CYP4B1 promoter activity, but 9-cis and all-trans retinoic acids increased promoter activity by up to 70% over control. Addition of both 9-cis and all-trans retinoic acids resulted in an additive effect increasing promoter activity by 2-fold. The increased promoter activity correlated with the presence of RAR/RXR binding motifs. Incubation of corneal organ culture for 24 hours in the presence of 9-cis and all-trans retinoic acids increased the synthesis of 12-HETE and 12-HETrE by 2-fold. The finding that retinoic acid increases the expression of the CYP4B1 gene and enhances production of the inflammatory 12-hydroxyeicosanoids in the corneal epithelium may provide a linkage between wound healing and inflammation in the ocular surface.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15006160     DOI: 10.1089/108076804772745473

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  9 in total

Review 1.  Corepressors of agonist-bound nuclear receptors.

Authors:  Igor Gurevich; Anthony M Flores; Brian J Aneskievich
Journal:  Toxicol Appl Pharmacol       Date:  2007-06-14       Impact factor: 4.219

2.  Retinoids activate RXR/CAR-mediated pathway and induce CYP3A.

Authors:  Shiyong Chen; Kun Wang; Yu-Jui Yvonne Wan
Journal:  Biochem Pharmacol       Date:  2009-08-15       Impact factor: 5.858

3.  Temporal changes of cytochrome P450 (Cyp) and eicosanoid-related gene expression in the rat brain after traumatic brain injury.

Authors:  Matthew Birnie; Ryan Morrison; Ramatoulie Camara; Kenneth I Strauss
Journal:  BMC Genomics       Date:  2013-05-04       Impact factor: 3.969

4.  MicroRNA-145 regulates human corneal epithelial differentiation.

Authors:  Sharon Ka-Wai Lee; Yufei Teng; Hoi-Kin Wong; Tsz-Kin Ng; Li Huang; Peng Lei; Kwong-Wai Choy; Yingpeng Liu; Mingzhi Zhang; Dennis Shun-Chiu Lam; Gary Hin-Fai Yam; Chi-Pui Pang
Journal:  PLoS One       Date:  2011-06-20       Impact factor: 3.240

5.  Effect of a Soluble Epoxide Hydrolase Inhibitor, UC1728, on LPS-Induced Uveitis in the Rabbit.

Authors:  Gillian J McLellan; Zeynep Aktas; Elizabeth Hennes-Beean; Aaron W Kolb; Inna V Larsen; Emily J Schmitz; Hilary R Clausius; Jun Yang; Sung Hee Hwang; Christophe Morisseau; Bora Inceoglu; Bruce D Hammock; Curtis R Brandt
Journal:  J Ocul Biol       Date:  2016-01-12

Review 6.  Molecular Functionality of Cytochrome P450 4 (CYP4) Genetic Polymorphisms and Their Clinical Implications.

Authors:  Yazun Bashir Jarrar; Su-Jun Lee
Journal:  Int J Mol Sci       Date:  2019-08-31       Impact factor: 5.923

7.  CYP4B1 is a prognostic biomarker and potential therapeutic target in lung adenocarcinoma.

Authors:  Xiaoling Liu; Yichen Jia; Changyuan Shi; Dechen Kong; Yuanming Wu; Tiantian Zhang; Anjie Wei; Dan Wang
Journal:  PLoS One       Date:  2021-02-16       Impact factor: 3.240

Review 8.  A Review of Topical and Systemic Vitamin Supplementation in Ocular Surface Diseases.

Authors:  Paolo Fogagnolo; Stefano De Cilla'; Micol Alkabes; Pierfilippo Sabella; Luca Rossetti
Journal:  Nutrients       Date:  2021-06-10       Impact factor: 5.717

Review 9.  Is Antiplatelet Therapy Contraindicated After Platelet-Rich Plasma Treatment? A Narrative Review.

Authors:  Matthew Magruder; Scott A Rodeo
Journal:  Orthop J Sports Med       Date:  2021-06-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.